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A BST R AC T   
 
Aim: To compare the importance of hemogram parameters in predicting the disease in diabetic 
patients with coronary artery ectasia (CAE) and normal coronary artery. 
Methods: The records of 7287 patients who underwent coronary angiography between January 2017 
and October 2019 were reviewed. After appropriate exclusions, diabetic patients were divided into 
coronary artery ectasia and normal coronary artery groups. A total of 248 patients were included in 
the study and hemogram parameters of these two groups were compared. 
Results: Compared to control group white blood count (WBC) [8 (4-13) vs. 7 (5-12) u/mm3, 
p=0.023], hemoglobin [13 (10-16) vs. 14 (10-20) gr/dL, p=0.015], red cell distribution width (RDW) 
[16 (14-20) vs. 15 (12-19) %, p=0.026], neutrophil [4.5 (2.1-11.4) vs. 4.0 (0.2-7.5) u/mm3, p=0.003], 
platelet counts (Plt) [266 (196-450) vs. 236 (163-362) k/mm3 p<0.001], platelet distribution width 
(PDW) (17.9 (16.2-20.4) vs. 17.7 (15.9-19.7) % p=0.011), mean platelet volume (MPV) [8.4 (6.4-
11.2) vs. 7.9 (6.6-10.1) Fl, p=0.015], plateletcrit (PCT) [0.20 (0.14-0.32) vs. 0.19 (0.13-0.26), 
p<0.001], and neutrophil lymphocyte ratio (NLR) [2.1 (1.0-9.7) vs. 1.6 (0.2-5.7), p=0.002] were 
significantly higher in CAE patients. 
Conclusion: The results of this study suggest that the increased some hemogram parameters may be 
useful in predicting disease in diabetic patients with CAE. 
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Introduction 
Coronary artery ectasia (CAE) is defined as the 
dilation of the coronary artery lumen. The term 
“ectasia'' is defined as the widespread 
expansion of a coronary artery, whereas focal 
coronary expansion is called “coronary 
aneurysm” [1]. CAE is a disease of the coronary 
arteries with abnormal dilatation of the 
coronary arteries [2]. The diameter of the 
dilated segment is 1.5 times the diameter of the 
normal adjacent segment [3]. CAE is a form of 
coronary atherosclerosis characterized by 
internal and external elastic lamina disorder [4, 
5]. The incidence of CAE ranges from 0.3 to 
4.990 [6, 7]. CAE can be seen due to genetics, 
Kawasaki disease, mycotic or septic emboli, 
Marfan syndrome, polyarthritis nodosa 
arthritis, Takayasu disease, systemic lupus 
erythematosus, hypertension, smoking, cocaine 
use, percutaneous transluminal coronary 
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angioplasty, stent, and directional coronary 
atherectomy. CAE is also related to apical 
hypertrophic cardiomyopathy [8].  
The etiopathogenesis of CAE is not fully 
understood [9, 10]. Although the main cause of 
coronary artery ectasia is unknown, 
atherosclerosis has been the most accused 
pathogenesis [11]. One of the most important 
indicators of atherosclerotic processes is 
endothelial dysfunction [12, 13]. CAE has 
commonly been evaluated as a variant of 
atherosclerotic heart disease. However; more 
intense inflammation has been detected in CAE 
than obstructive coronary artery disease (CAD) 
[14] 
Histology is usually due to chronic vascular 
inflammation that shows thickened fibrotic 
intima with lipid accumulation [15]. The 
thinning of the tunica media environment 
associated with chronic inflammation is 
considered to be the main pathogenesis of 
extensive remodeling [10]. Ectasia can lead to 
slow flow in the coronary arteries, dissection, 
thrombus formation, and vasospasm [16, 17]. 
The primary symptom of CAE is chest pain. 
Ectasia can cause the acute coronary syndrome, 
ventricular arrhythmias and sudden cardiac 
death without severe coronary artery stenosis 
[7]. Coronary angiography is the gold standard 
test for the diagnosis of coronary artery ectasia 
[8]. 
Diabetes mellitus (DM) is an important public 
health problem due to high morbidity and 
mortality from microvascular and 
macrovascular complications [18]. Endothelial 
dysfunction is the basis for the development of 
long-term complications of diabetes [19]. The 
activity and aggregation of platelets are 
important in terms of thrombus during the 
atherogenesis process [20, 21]. Therefore, in 
this study, we aimed to evaluate the hemogram 
parameters of diabetic CAE patients. 
Materials and Methods 
We reviewed 7287 angiograms performed 
between January 2017 and October 2019, from 
Bolu Abant Izzet Baysal University Medical 
Faculty Hospital. "The Siemens Axiom Artis 
diagnostic device (Siemens Healthcare GmbH, 
Forchheim, Germany)" was used to perform 
coronary angiography. Coronary angiography 
(CAG) was performed to investigate ischemic 
heart diseases based on clinical indications. The 
study was conducted in accordance with the 
ethical approval of the University Ethics 
Committee. (Date: 24/10/2019; Decision 
number: 2019/217) Data about patients were 
obtained from the institution's database and 
patient files. CAG images recorded in digital 
format were evaluated visually by two blind 
cardiologists and patients diagnosed as CAE 
were included in the study. Patients included in 
the study were selected from patients with 
chronic coronary syndrome (CCS). Patients 
with clear CAE evidence were selected. The 
baseline demographic data and clinical 
cardiovascular risk factors; hypertension, 
diabetes mellitus, smoking or ex-smoking, 
family history of CAD, dyslipidemia weight 
and height were determined from hospital 
records. There was no significant difference in 
demographic parameters between CAE patients 
and the control group (normal coronary 
angiography). Subjects with a history of 
chronic diseases such as heart failure (ejection 
fraction <50%), acute coronary syndrome 
(ACS),  previous coronary artery bypass 
grafting, percutaneous coronary intervention, 
significant valve disease, patients under 18 
years of age, atrial fibrillation, hypertension, 
smoking, autoimmune diseases, pregnancy, 
iatrogenic ectasia, myocarditis, pericarditis, 
acute and chronic lung disease, obstructive 
sleep apnea, chronic inflammation, active 
infection, cancer, immunosuppressive therapy, 
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hypo/hyperthyroidism, stroke, mental 
retardation, delirium, dementia, any 
hematological abnormality (sickle cell anemia, 
thrombocytopenia etc.), and antiplatelet / 
anticoagulant agents and steroid users, liver or 
kidney failure and electrolyte imbalance were 
excluded from the study. 
Statistical analysis 
Statistical analysis was conducted with SPSS 
software (SPSS 22.0 for Windows, IBM Co, 
Chicago, IL, USA). Kolmogorov Smirnov test 
was used to determine distribution normality. 
Normal variables were compared with the T-
test and expressed as mean ± standard 
deviation. Mann Whitney U test was used for 
variables showing the abnormal distribution 
and expressed as median (IQR: interquartile 
interval). A chi-square test was used for 
comparison of nonparametric variables. A p-
value lower than 0.05 was considered 
statistically significant. 
 
Results  
We enrolled 248 individuals including 124 
CAE patients (mean age: 61.4±10.9 years) and  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
124 control persons (mean age: 59.3±10.3 
years). The mean age was 61.4±10.9 and 
59.3±10.3 in the patient and the control groups, 
respectively. Frequencies of sex, and body 
mass index (BMI) were not significantly 
different between the patient and the control 
groups (Table 1). Compared to control group 
white blood count (WBC) [8 (4-13) vs. 7 (5-12) 
u/mm3, p=0.023], hemoglobin [13 (10-16) vs. 
14 (10-20) gr/dL, p=0.015], red cell 
distribution width (RDW) [16 (14-20) vs. 15 
(12-19) %, p=0.026], neutrophil [4.5 (2.1-11.4) 
vs. 4.0 (0.2-7.5) u/mm3, p=0.003], platelet 
counts (Plt) [266 (196-450) vs. 236 (163-362) 
k/mm3 p<0.001], platelet distribution width 
(PDW) (17.9 (16.2-20.4) vs. 17.7 (15.9-19.7) % 
p=0.011), mean platelet volume (MPV) [8.4 
(6.4-11.2) vs. 7.9 (6.6-10.1) Fl, p=0.015], 
plateletcrit (PCT) [0.20 (0.14-0.32) vs. 0.19 
(0.13-0.26), p=0.001], and neutrophil 
lymphocyte ratio (NLR) [2.1 (1.0-9.7) vs. 1.6 
(0.2-5.7), p=0.002] were significantly higher in 
CAE patients. There was no significant difference 
between the two groups in terms of other 
biochemical and hemogram values (Table 2). 
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Discussion 
This study showed that hemogram parameter 
levels were different between CAE patients and 
controls. To the best of our knowledge, this is  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the first study to evaluate hemogram 
parameters in patients with diabetic coronary 
artery ectasia.  
CAE has been related to rising morbidity and 
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mortality [15]. Angiographies performed to 
investigate ischemic heart disease indicate an 
average of 1-5% CAE [4]. CAE is thought an 
atypical variant of coronary atherosclerosis, 
that characterized by disruption of the elastic 
lamina [4, 5]. The key role of inflammation in 
the initiation and progression of atherosclerosis 
is well known [22, 23]. 
Inflammation plays a major role in the 
development of atherosclerosis and in all stages 
of CAD [24]. Chronic inflammation is 
considered to play a role in the etiology of CAE 
[25, 26]. In our study, as in previous 
studies[27], the level of inflammatory 
biomarker CRP was found to be high. 
Circulating white blood cell count (WBC) and 
its subtypes and their relationship to 
cardiovascular outcomes have been evaluated 
in previous studies [28]. Leukocyte, monocyte, 
and neutrophil levels have found to be high in 
patients with isolated CAE [29]. Neutrophil 
lymphocyte ratio (NLR) is being evaluated as a 
new marker of inflammation. Recently, it has 
been suggested that the NLR rate is a new 
biomarker for cardiovascular events and 
prognosis [30]. Balta et al [31] investigated the 
relationship of NLR in isolated CAE patients 
and found it to be high. In our study, this rate 
was high in CAE patients. 
Increase in Mean platelet volume (MPV) and 
platelet distribution width (PDW) in diabetic 
patients is thought to be related to diabetic 
vascular complications [32]. MPV and PDW 
levels have been found to be high in diabetic 
patients with macrovascular complications 
[33]. MPV and PDW were higher in diabetic 
patients with thromboembolic complications 
[34]. This confirms that CAE is an 
atherosclerotic disease. MPV, an indicator of 
platelet activation, has an independent effect on 
the pathophysiology of atherosclerosis. MPV 
levels were high in patients with acute 
myocardial infarction, unstable angina pectoris, 
and congestive heart failure [35]. As in our 
study, MPV levels were found to be high in 
CAE patients in previous studies [36]. In 
contrast to this study, in our study, all CAE 
patients were diabetic. In our study, patients 
with coronary artery ectasia had higher MPV 
than normal coronary arteries. 
Platelets have an important role in the 
pathogenesis of homeostasis and thrombosis 
[37]. It has been shown in previous studies that 
platelet indices are increased in diabetic 
patients [38]. We also found these indexes high 
in our study. 
 
Conclusions 
Routine hematological analyzes are important, 
simple, effortless and cost-effective tests. These 
tests may be predictive of CAE, which requires 
prospective large-scale randomized control 
trials. 
 
Funding: There is no financial support and 
sponsorship                                               
Conflict of Interest: The authors declare that 
they have no conflict of interest. 
Ethical statement: The study was conducted in 
accordance with the ethical approval of the 
University Ethics Committee. (Date: 
24/10/2019; Decision number: 2019/217). 
 
ORCID iD of the author(s) 
Mehmet Inanir / 0000-0003-1784-3584 
 
References 
[1] Endoh S, Andoh H, Sonoyama K, et al. 
Clinical Features of Coronary Artery 
Ectasia. J Cardiol. 2004; 43(2):45–52. 
[2] Befeler B, Aranda MJ, Embi A, et al. 
Coronary artery aneurysms: study of the 
etiology, clinical course and effect on left 
                                              Mehmet Inanir / Exp Biomed Res. 2020; 3(2):63-70 
   
 
68 
 
ventricular function and prognosis. Am J 
Med. 1977; 62(4):597–607. 
[3] Zeina AR, Sharif D, Blinder J, et al. 
Noninvasive assessment of coronary artery 
ectasia using multidetector computed 
tomography. Coron Artery Dis. 2007; 
18(3):175-80. 
[4] Sultana R, Sultana N, Ishaq M, et al. The 
prevalence and clinical profile of 
angiographic coronary ectasia. J Pak Med 
Assoc. 2011; 61(4):372-75. 
[5] Demopoulos VP, Olympios CD, Fakiolas 
CN, et al. The natural history of aneurysmal 
coronary artery disease. Heart. 1997; 
78(2):136-41. 
[6] Díaz-Zamudio M, Bacilio-Pérez U, Herrera-
Zarza MC, et al. Coronary artery aneurysms 
and ectasia: role of coronary CT 
angiography. Radiographics. 2009; 
29(7):1939-54. 
[7] al-Harthi SS, Nouh MS, Arafa M, et al. 
Aneurysmal dilatation of the coronary 
arteries: diagnostic patterns and clinical 
significance. Int J Cardiol. 1991; 30(2):191-
94. 
[8] Manginas A, Cokkinos DV. Coronary artery 
ectasias: imaging, functional assessment and 
clinical implications. Eur Heart J. 2006; 
27(9):1026-31. 
[9] Sarli B, Baktir AO, Saglam H, et al. 
Neutrophil-to-lymphocyte ratio is associated 
with severity of coronary artery 
ectasia. Angiology. 2014; 65(2):147-51. 
[10] Antoniadis AP, Chatzizisis YS, Giannoglou 
GD. Pathogenetic mechanisms of coronary 
ectasia. Int J Cardiol. 2008; 130(3):335–43. 
[11] Mavrogeni S. Coronary artery ectasia: from 
diagnosis to treatment. Hellenic J Cardiol. 
2010; 51(2):158–63. 
[12] Neunteufl T, Katzenschlager R, Hassan A, et 
al. Systemic endothelial dysfunction is 
related to the extent and severity of coronary 
artery disease. Atherosclerosis. 1997; 
129(1):111–18. 
[13] Li JJ, He JG, Nan JL, et al. Is systemic 
inflammation responsible for coronary 
artery ectasia? Int J Cardiol. 2008; 
130(2):e69–e70. 
[14] Aydin M, Tekin IO, Dogan SM, et al. The 
levels of tumor necrosis factor-alpha and 
interleukin-6 in patients with isolated 
coronary artery ectasia. Mediators Inflamm. 
2009; 2009:106145. 
[15] Zografos TA, Korovesis S, Giazitzoglou E, 
et al. Clinical and angiographic 
characteristics of patients with coronary 
artery ectasia. Int J Cardiol. 2013; 
167(4):1536–41. 
[16] Papadakis MC, Manginas A, Cotileas P, et 
al. Documentation of slow coronary flow by 
the TIMI frame count in patients with 
coronary ectasia. Am J Cardiol. 2001; 
88(9):1030–32. 
[17] Krüger D, Stierle U, Herrmann G, et al. 
Exercise-induced myocardial ischemia in 
isolated coronary artery ectasias and 
aneurysms ("dilated coronopathy"). J Am 
Coll Cardiol. 1999; 34(5):1461–70. 
[18] American Diabetes Association. 2. 
Classification and Diagnosis of 
Diabetes: Standards of Medical Care in 
Diabetes-2019. Diabetes Care. 2019; 
42(Suppl 1):S13–S28. 
[19] Oliveira JEP, Vencio S. Diretrizes da 
SociedadeBrasileira de Diabetes: 2013-
2014/SociedadeBrasileira de Diabetes. São 
Paulo: AC Farmacêutica. 2014:1-360. 
[20] Endler G, Klimesch A, Sunder-Plassmann 
H, et al. Mean platelet volume is an 
                                              Mehmet Inanir / Exp Biomed Res. 2020; 3(2):63-70 
   
 
69 
 
independent risk factor for myocardial 
infarction but not for coronary artery 
disease. Br J Haematol. 2002; 117(2):399–
404. 
[21] Farias MG, Dal Bó S. The clinical and 
laboratory importance of mean platelet 
volume. J. Bras. Patol. Med. Lab. 2010; 
46(4):275-82. 
[22] Ozde C, Korkmaz A, Kundi H, et al. 
Relationship between plasma levels of 
soluble CD40 ligand and the presence and 
severity of isolated coronary artery 
ectasia. Clin Appl Thromb Hemost. 2018; 
24(2):379–86. 
[23] Zhao ZW, Ren YG, Liu J. Low Serum 
Adropin Levels are Associated with 
Coronary Slow Flow Phenomenon. Acta 
Cardiol Sin. 2018; 34(4):307–12. 
[24] Hansson GK. Inflammation, atherosclerosis, 
and coronary artery disease. N Engl J Med. 
2005; 352(16):1685–95. 
[25] Furtado M, Katzman MA. Examining the 
role of neuroinflammation in major 
depression. Psychiatry Res. 2015; 229(1-
2):27–36. 
[26] Corrado E, Rizzo M, Coppola G, et al. An 
update on the role of markers of 
inflammation in atherosclerosis. J 
Atheroscler Thromb. 2010; 17(1):1–11. 
[27] Ozbay Y, Akbulut M, Balin M, et al. The 
level of hs-CRP in coronary artery ectasia 
and its response to statin and angiotensin-
converting enzyme inhibitor 
treatment. Mediators Inflamm. 2007; 
2007:89649.  
[28] Horne BD, Anderson JL, John JM, et al. 
Which white blood cell subtypes predict 
increased cardiovascular risk? J Am Coll 
Cardiol. 2005; 45(10):1638–43. 
[29] Kocaman SA, Taçoy G, Sahinarslan A, et al. 
Relationship between total and differential 
leukocyte counts and isolated coronary 
artery ectasia. Coron Artery Dis. 2008; 
19(5):307–10. 
[30] Guasti L, Dentali F, Castiglioni L, et al. 
Neutrophils and clinical outcomes in 
patients with acute coronary syndromes 
and/or cardiac revascularisation. A 
systematic review on more than 34,000 
subjects. Thromb Haemost. 2011; 
106(4):591–99. 
[31] Balta S, Demirkol S, Celik T, et al. 
Association between coronary artery ectasia 
and neutrophil-lymphocyte 
ratio. Angiology. 2013; 64(8):627–32. 
[32] Jindal S, Gupta S, Gupta R, et al. Platelet 
indices in diabetes mellitus: indicators of 
diabetic microvascular 
complications. Hematology. 2011; 
16(2):86–89. 
[33] Alhadas KR, Santos SN, Freitas MMS, et al. 
Are platelet indices useful in the evaluation 
of type 2 diabetic patients? J. Bras. Patol. 
Med. Lab. 2016; 52(2):96-102. 
[34] Jabeen F, Fawwad A, Rizvi HA, et al. Role 
of platelet indices, glycemic control and hs-
CRP in pathogenesis of vascular 
complications in type-2 diabetic patients. 
Pak J Med Sci. 2013; 29(1):152-56.  
[35] Huczek Z, Kochman J, Filipiak KJ, et al. 
Mean platelet volume on admission predicts 
impaired reperfusion and long-term 
mortality in acute myocardial infarction 
treated with primary percutaneous coronary 
intervention. J Am Coll Cardiol. 2005; 
19;46(2):284-90.  
[36] Demir S, Avsar MK, Karakaya Z, et al. 
Increased mean platelet volume is associated 
                                              Mehmet Inanir / Exp Biomed Res. 2020; 3(2):63-70 
   
 
70 
 
with coronary artery ectasia. Postepy 
Kardiol Interwencyjnej. 2013; 9(3):241–45. 
[37] Li S, Zhu CG, Guo YL, et al. The 
relationship between the plasma PCSK9 
levels and platelet indices in patients with 
stable coronary artery disease. J Atheroscler 
Thromb. 2015; 22(1):76–84. 
[38] Inanir M, Gunes Y, Sincer I. Platelet indices 
in type 1 diabetes mellitus. Exp Biomed Res. 
2019; 2(2):69-75. 
